表 2.

Pg感染及IFNGR1表达与ESCC患者临床病理特征的相关性分析

Correlation of Pg infection and IFNGR1 expression with clinicopathological characteristics of ESCC patients

Factors		n	IFNGR1		χ2	P	PG		χ2	P
			(-)	(+)			(-)	(+)
Gender	Female	21	8 (16.0%)	13 (26.0%)	7.239	0.007	20 (40.0%)	1 (2.0%)	18.733	0.0001
	Male	29	22 (44.0%)	7 (14.0%)			10 (20.0%)	19 (38.0%)
Age (year)	≤60	19	12 (24.0%)	7 (14.0%)	0.127	0.721	15 (30.0%)	4 (8.0%)	4.584	0.032
	≥60	31	18 (36.0%)	13 (26.0%)			15 (30.0%)	16 (32.0%)
Smoke	No	21	9 (18.0%)	12 (24.0%)	4.433	0.035	19 (38.0%)	2 (4.0%)	14.012	0.0001
	Yes	29	21 (42.0%)	8 (16.0%)			11 (22.0%)	18 (36.0%)
Alcohol	No	27	13 (26.0%)	14 (28.0%)	3.435	0.064	24 (48.0%)	3 (6.0%)	20.411	0.0001
	Yes	23	17 (34.0%)	6 (12.0%)			6 (12.0%)	17 (34.0%)
Invasion	< Serous membrane	23	11 (22.0%)	12 (24.0%)	2.630	0.105	20 (40.0%)	3 (6.0%)	12.896	0.0001
	≥Serous membrane	27	19 (38.0%)	8 (16.0%)			10 (20.0%)	17 (34.0%)
Division	Low	24	13 (26.0%)	11 (22.0%)	0.654	0.419	20 (40.0%)	4 (8.0%)	10.47	0.0001
	High	26	17 (34.0%)	9 (18.0%)			10 (20.0%)	16 (32.0%)
Lymph Node Metastasis	No	24	8 (16.0%)	6 (12.0%)	0.066	0.797	12 (24.0%)	2 (4.0%)	5.357	0.021
	Yes	36	22 (44.0%)	14 (28.0%)			18 (36.0%)	18 (36.0%)
TNM	Ⅰ	23	5 (10.0%)	8 (16.0%)	3.412	0.332	12 (24.0%)	12 (24.0%)	14.672	0.002
	Ⅱ	12	8 (16.0%)	4 (8.0%)			7 (14.0%)	5 (10.0%)
	Ⅲ	16	11 (22.0%)	5 (10.0%)			10 (20.0%)	6 (12.0%)
	Ⅳ	9	6 (12.0%)	3 (6.0%)			1 (2.0%)	8 (16.0%)